Stock Day Media

Trevi Therapeutics, Inc. Discusses Commercialization for Its Investigational Therapy, Haduvio, with The Stock Day Podcast


Listen Later

The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (TRVI) (“the Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of prurigo nodularis (PN) and chronic cough in idiopathic pulmonary fibrosis (IPF). President and CEO of the Company, Jennifer Good, joined Stock Day host Sever Copley. 


Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy
...more
View all episodesView all episodes
Download on the App Store

Stock Day MediaBy Stock Day Media

  • 4.4
  • 4.4
  • 4.4
  • 4.4
  • 4.4

4.4

31 ratings


More shows like Stock Day Media

View all
Bad Friends by Bobby Lee & Andrew Santino

Bad Friends

14,128 Listeners